欧洲骨胶市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲骨胶市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Published Report
  • Jan 2020
  • Europe
  • 350 页面
  • 桌子數: 40
  • 图号: 24

Europe Bone Glue Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2026 –2030
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>欧洲骨胶市场,按应用(椎体成形术、关节成形术、骨科、运动损伤、颌面外科、创伤等)、最终用户(医院、门诊手术中心、专业骨科诊所)、分销渠道(直销、零售)、国家(德国、英国、法国、意大利、西班牙和瑞士)、行业趋势和预测到 2030 年

欧洲骨胶市场市场分析和洞察:欧洲骨胶市场

欧洲骨胶市场预计将在 2025 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析,在 2025 年至 2030 年的预测期内,该市场以 32.6% 的复合年增长率增长,预计到 2030 年将达到 38,107.69 万美元。骨胶竞争优势的增强和骨胶研发的强大是市场增长的因素。

骨胶是一种可注射的合成湿场生物可吸收生物材料。骨胶是一种功能性强的骨粘合剂,​​能够与湿金属和骨组织形成承重粘合。骨粘合剂材料在 pH 值中性水环境中具有机械和化学稳定性,可在体内吸收和降解,不会损失与骨的粘合力,导致骨连续沉积在暴露表面上。骨胶可用于椎体成形术、关节成形术、整形外科、运动损伤、神经外科、颌面外科、创伤等。

骨胶是磷酸四钙和磷酸丝氨酸的独家配方,磷酸四钙是一种广泛用于市场上骨制品的陶瓷,磷酸丝氨酸是一种在人体中常见的高级氨基酸。骨胶固化成仿生结构,与水性介质混合时具有机械稳定性和即时承重强度。这种完全可吸收的合成生物材料可以通过微创手术注入骨缺损和空隙,并在骨与骨和骨与金属粘合中提供牢固的固定。骨质疏松症患病率的增加促进了市场的增长。

与过去几年相比,骨胶药物数量的增加将加速市场的增长。骨质疏松症的患病率在发达国家和发展中国家都在增加。例如,国际骨质疏松症基金会表示,到 2025 年,欧盟的骨质疏松症病例将增加到 3390 万(2010 年为 2750 万)。骨胶研究活动的增加也将推动市场的发展。监管机构对药物的严格监管程序阻碍了骨胶市场的增长。

本骨胶市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。

欧洲骨胶市场范围和市场规模

欧洲骨胶市场根据应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据应用,市场分为椎体成形术、关节成形术、骨科、运动损伤、颌面外科、创伤等。椎体成形术在市场上占据主导地位,因为它是一种微创手术,需求量很大,需要可吸收材料来固定脊柱。
  • 根据最终用户,市场分为医院、门诊手术中心和专科骨科诊所。医院占比最高,患者更喜欢这些设施,因为它们提供除骨骼固定之外所需的各种附加服务。
  • 根据分销渠道,市场分为直销和零售。直销在 B2B 产品交易中利润最高,因此占据市场主导地位。

欧洲骨胶市场国家级分析

对欧洲骨胶市场进行了分析,并按上述应用、最终用户和分销渠道提供了市场规模信息。

欧洲骨胶市场报告涉及的国家包括德国、英国、法国、意大利、西班牙和瑞士。

欧洲骨胶市场正在增长,这是由于骨胶制造商对骨胶的研发不断增加,以实现骨胶销售和使用的商业化,因此预计骨胶市场在 2025 年至 2030 年的预测期内将以显著的增长率增长。

由于骨胶的研究和开发以及骨质疏松症患病率的不断上升,欧洲骨胶市场正在增长,预计在 2025 年至 2030 年的预测期内将以显著的增长率增长。此外,Oxervate 是骨胶中最有效的药物之一,于 2108 年首次在欧洲上市。德国是发达国家,拥有更多的制药和设备公司,因此市场份额最高。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

竞争格局和骨胶市场份额分析

欧洲骨胶市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对欧洲骨胶市场的关注有关。

报告中涉及的主要参与者是 Launchpad Medical。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE BONE GLUE MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 PRODUCTS LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 SECONDARY SOURCES

2.9 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 RESTRAINT

5.1.1 STRINGENT REGULATORY SCENARIO

5.2 OPPORTUNITIES

5.2.1 INCREASING PREVALENCE OF OSTEOPOROSIS

5.2.2 INCREASING RESEARCH ACTIVITIES FOR BONE GLUE

5.2.3 UNMET MEDICAL NEEDS IN OSTEOPOROSIS MANAGEMENT

5.2.4 INCREASING HEALTHCARE EXPENDITURE IN ORTHOPEDIC

5.2.5 RISING CASES OF MULTIPLE FRACTURE INJURIES AND OTHER BONE RELATED DISORDERS

5.2.6 COMPETITIVE ADVANTAGES

5.3 CHALLENGE

5.3.1 AVAILABILITY OF OTHER ALTERNATIVES

6 EUROPE BONE GLUE MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 VERTEBROPLASTY

6.3 ARTHROPLASTY

6.4 ORTHOPAEDICS

6.5 SPORTS INJURIES

6.6 MAXILLOFACIAL SURGERY

6.7 TRAUMA

6.8 OTHERS

7 EUROPE BONE GLUE MARKET, BY END-USER

7.1 OVERVIEW

7.2 HOSPITALS

7.3 AMBULATORY SURGICAL CENTERS

7.4 SPECIALIZED ORTHOPEDICS CLINICS

8 EUROPE BONE GLUE MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 DIRECT SALES

8.3 RETAIL SALES

9 EUROPE BONE GLUE MARKET, BY GEOGRAPHY

9.1 EUROPE

9.1.1 GERMANY

9.1.2 UNITED KINGDOM

9.1.3 FRANCE

9.1.4 ITALY

9.1.5 SPAIN

9.1.6 SWITZERLAND

10 COMPANY PROFILE

10.1 LAUNCHPAD MEDICAL

10.1.1 COMPANY SNAPSHOT

10.1.2 CLINICAL TRIAL

10.1.3 PRODUCT PORTFOLIO

10.1.4 RECENT DEVELOPMENTS

11 QUESTIONNAIRE

12 RELATED REPORTS

表格列表

TABLE 1 LIST OF ITEMS FOR COMMON SUBMISSION FORMAT FOR OF MEDICAL DEVICES IN INDIA, USA AND EUROPEAN UNION

TABLE 2 COSTS OF OSTEOPOROSIS BY RACE OR ETHNICITY, 2005–2025 (USD MILLIONS)

TABLE 3 JAPAN PATIENTS WITH HIP FRACTURE AGED 35 YEARS OR OVER

TABLE 4 EUROPE BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 5 EUROPE VERTEBROPLASTY IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 6 EUROPE ARTHROPLASTY IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 7 EUROPE ORTHOPAEDICS IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 8 EUROPE SPORTS INJURIES IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 9 EUROPE SPORTS INJURIES IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 10 EUROPE SPORTS INJURIES IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 11 EUROPE OTHERS IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 12 EUROPE BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 13 EUROPE HOSPITALS IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 14 EUROPE AMBULATORY SURGICAL CENTERS IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 15 EUROPE SPECIALIZED ORTHOPEDICS CLINICS IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 16 EUROPE BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 17 EUROPE DIRECT SALES IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 18 EUROPE RETAIL SALES IN BONE GLUE MARKET, BY REGION, 2025-2030 (USD THOUSAND)

TABLE 19 EUROPE BONE GLUE MARKET, BY COUNTRY, 2025-2030 (USD THOUSAND)

TABLE 20 EUROPE BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 21 EUROPE BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 22 EUROPE BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 23 GERMANY BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 24 GERMANY BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 25 GERMANY BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 26 UNITED KINGDOM BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 27 UNITED KINGDOM BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 28 UNITED KINGDOM BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 29 FRANCE BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 30 FRANCE BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 31 FRANCE BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 32 ITALY BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 33 ITALY BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 34 ITALY BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 35 SPAIN BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 36 SPAIN BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 37 SPAIN BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

TABLE 38 SWITZERLAND BONE GLUE MARKET, BY APPLICATION, 2025-2030 (USD THOUSAND)

TABLE 39 SWITZERLAND BONE GLUE MARKET, BY END-USER, 2025-2030 (USD THOUSAND)

TABLE 40 SWITZERLAND BONE GLUE MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

图片列表

FIGURE 1 EUROPE BONE GLUE MARKET: SEGMENTATION

FIGURE 2 EUROPE BONE GLUE MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE BONE GLUE MARKET: DROC ANALYSIS

FIGURE 4 EUROPE BONE GLUE MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE BONE GLUE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE BONE GLUE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE BONE GLUE MARKET: SEGMENTATION

FIGURE 8 INCREASING NUMBER OF OSTEOPOROSIS AND INCREASING PREVALENCE OF MULTIPLE FRACTURE INJURIES AND OTHER BONE RELATED DISORDERS IS EXPECTED TO CREATE OPPORTUNITIES IN EUROPE BONE GLUE MARKET IN THE FORECAST PERIOD OF 2025 TO 2030

FIGURE 9 VERTEBROPLASTY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF EUROPE BONE GLUE MARKET IN 2025 & 2030

FIGURE 10 RESTRAINT, OPPORTUNITIES AND CHALLENGE OF EUROPE BONE GLUE MARKET

FIGURE 11 ESTIMATED NUMBER OF INDIVIDUALS AGED 50+ WITH OSTEOPOROSIS, IN 2015

FIGURE 12 PERCENTAGE CHANGE IN RECENT U.S. HEALTHCARE SPENDING TRENDS

FIGURE 13 EUROPE BONE GLUE MARKET DOMINATED BY VERTEBROPLASTY (2025)

FIGURE 14 EUROPE BONE GLUE MARKET: BY APPLICATION, 2025-2030 (USD THOUSAND)

FIGURE 15 EUROPE BONE GLUE MARKET: BY APPLICATION, CAGR (2025-2030)

FIGURE 16 EUROPE BONE GLUE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 17 EUROPE BONE GLUE MARKET DOMINATED BY HOSPITALS (2025)

FIGURE 18 EUROPE BONE GLUE MARKET: BY END-USER, 2025-2030 (USD THOUSAND)

FIGURE 19 EUROPE BONE GLUE MARKET: BY END-USER, CAGR (2025-2030)

FIGURE 20 EUROPE BONE GLUE MARKET: BY END-USER, LIFELINE CURVE

FIGURE 21 EUROPE BONE GLUE MARKET DOMINATED BY DIRECT SALES (2025)

FIGURE 22 EUROPE BONE GLUE MARKET: BY DISTRIBUTION CHANNEL, 2025-2030 (USD THOUSAND)

FIGURE 23 EUROPE BONE GLUE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2030)

FIGURE 24 EUROPE BONE GLUE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Bone Glue Market size will be worth USD 38,107.69 thousand by 2030.
The Europe Bone Glue Market growth rate is 32.6% by 2030.
The Increasing prevalence of osteoporosis and Increased number of bone glues medication as compared to the past few years are the growth drivers of the Europe Bone Glue Market.
The application, end user, and distribution channel are the factors on which the Europe Bone Glue Market research is based.
The major company covered in the report is Launchpad Medical.